Pulse Co-oximeter

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Commercializzato da:

Masimo Australia Pty Ltd

Classe:

Class IIb

Prodotto da:

Masimo Corporation 52 Discovery, Irvine, CA, 92618 United States Of America

Area terapeutica:

46201 - Pulse Co-oximeter

Indicazioni terapeutiche:

The device is indicated for the continuous non-invasive monitoring of functional oxygen saturation of arterial haemoglobin (SpO2), pulse rate, carboxyhemoglobin saturation, methemoglobin saturation, total haemoglobin concentration, and/or respiratory rate.; and is indicated for use with adult, paediatric, and neonatal patients during both no motion and motion conditions, and for patients who are well or poorly perfused in hospitals, hospital-type facilities, and mobile environments. The device has an additional mode to provide clinicians with a guided tool to help screen newborns for Critical Congenital Heart Disease (CCHD) per the established CCHD Screening protocol.

Stato dell'autorizzazione:

A

Data dell'autorizzazione:

2008-12-03